Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05157659
What this trial is testing

[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer.

Who this might be right for
Non-Small Cell Lung Cancer
Amsterdam UMC, location VUmc 10
Not applicableNot Yet RecruitingNCT07000396
What this trial is testing

The Role of Mucosal Associated Invariant t Lymphocytes in Breast Cancer

Who this might be right for
Breast Cancer
Assiut University 74
Early research (Phase 1)UnknownNCT04193098
What this trial is testing

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerSecond-line Treatment
Tianjin Medical University Cancer Institute and Hospital 10
Not applicableStudy completedNCT00006443
What this trial is testing

Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00014235
What this trial is testing

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more
Fred Hutchinson Cancer Center 160
Early research (Phase 1)Ended earlyNCT00354185
What this trial is testing

PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+57 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT03312335
What this trial is testing

Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Onur Boyman, MD 16
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Not applicableUnknownNCT03313102
What this trial is testing

Study of T Lymphocytes in Patients With Horton Disease

Who this might be right for
Horton Disease
Centre Hospitalier Universitaire Dijon 60
Early research (Phase 1)Active Not RecruitingNCT03180216
What this trial is testing

T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation

Who this might be right for
Viral InfectionsBone Marrow Transplant Infection
Children's National Research Institute 32
Early research (Phase 1)Study completedNCT00438984
What this trial is testing

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 11
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Not applicableStudy completedNCT01583972
What this trial is testing

Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function

Who this might be right for
Vitamin A Deficiency
USDA, Western Human Nutrition Research Center 300
Testing effectiveness (Phase 2)Study completedNCT01213407
What this trial is testing

Dendritic Cell Cancer Vaccine for High-grade Glioma

Who this might be right for
Glioblastoma Multiforme
Activartis Biotech 87
Early research (Phase 1)UnknownNCT00006209
What this trial is testing

Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Aaron Diamond AIDS Research Center 24
Early research (Phase 1)UnknownNCT00006100
What this trial is testing

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06530303
What this trial is testing

Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer

Who this might be right for
Colorectal CancerColon CancerRectum Cancer
Essen Biotech 85
Not applicableNot Yet RecruitingNCT07642297
What this trial is testing

TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)

Who this might be right for
Systemic Sclerosis (SSc)Diffuse Cutaneous Systemic SclerosisSkin Fibrosis
Fondazione Policlinico Universitario Campus Bio-Medico 20
Testing effectiveness (Phase 2)Study completedNCT00003635
What this trial is testing

506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents

Who this might be right for
Leukemia
GlaxoSmithKline
Early research (Phase 1)Ended earlyNCT01678443
What this trial is testing

Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+30 more
Fred Hutchinson Cancer Center 2
Next Page